Effects of Licorice on clinical symptoms and laboratory signs in moderately ill patients with pneumonia from COVID-19: A structured summary of a study protocol for a randomized controlled trial
This study is being conducted at Shahid Mohammadi Hospital, Bandar Abbas, Iran.ParticipantsBoth male and female patients with ≥18 years of age (≥ 35 kg of weight), admitted at the Shahid Mohammadi Hospital, Hormozgan University of Medical Sciences, Bandar Abbas for treatment, screened for the following criteria.Inclusion criteria:1. Confirmed diagnosis of SARS-CoV-2 infection (via polymerase chain reaction [PCR] and/or antibody test).2. Presenting as moderate COVID-19 pneumonia (via chest computed tomography (CT) and/or X-ray) requiring hospitalization.3. Hospitalized ≤48 hours.4. Signing informed consent and will...
Source: Trials - September 15, 2020 Category: Research Source Type: clinical trials

Effectiveness of NextDose for Warfarin Dose Individualization
Condition:   Thrombosis Embolism Intervention:   Device: NextDose (nextdose.org) Sponsors:   The First Affiliated Hospital of Soochow University;   National Natural Science Foundation of China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2020 Category: Research Source Type: clinical trials

A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes
Condition:   Atrial Fibrillation Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Warfarin Sponsors:   Bayer;   Janssen Research and Development LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2020 Category: Research Source Type: clinical trials

Gene-guided Warfarin for Anticoagulation Therapy
Condition:   Stroke Interventions:   Device: Gene detection (CYP2C9*3, VKORC1);   Drug: Warfarin Sodium Sponsor:   First Affiliated Hospital Xi'an Jiaotong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2020 Category: Research Source Type: clinical trials

The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial
AbstractObjectivesThe primary objective is to determine the efficacy of a single dose of ivermectin, administered to low risk, non-severe COVID-19 patients in the first 48 hours after symptom onset to reduce the proportion of patients with detectable SARS-CoV-2 RNA by Polymerase Chain Reaction (PCR) test from nasopharyngeal swab at day 7 post-treatment.The secondary objectives are:To assess the efficacy of ivermectin to reduce the SARS-CoV-2 viral load in the nasopharyngeal swab at day 7 post treatment.To assess the efficacy of ivermectin to improve symptom progression in treated patients.To assess the proportion of seroco...
Source: Trials - June 8, 2020 Category: Research Source Type: clinical trials

Cost-Effectiveness Study on Establishing a Warfarin Counseling Clinic for Egyptian Patients With Mitral Valve Prostheses
Condition:   Cost Effectiveness Intervention:   Other: Education and counseling Sponsor:   Ain Shams University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2020 Category: Research Source Type: clinical trials

A Study of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants
Condition:   Uterine Hemorrhage Interventions:   Drug: Direct oral anticoagulant (DOACs);   Drug: Warfarin Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2020 Category: Research Source Type: clinical trials